SCHEMBL2326114

SCHEMBL2326114

CCN(CC)CCCOc1cc2nccc(Oc3ccc(N(CCc4ccccc4)C(=O)C(N)=O)cc3F)c2cc1OC

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 19/20 0.52
▸ KDR P35968 1/20 0.47
▸ AXL P30530 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200943 0.92 MET (0.53) METKDR
SCHEMBL3829110 0.84 MET (0.47) METKDR
SCHEMBL3855044 0.84 MET (0.55) METKDR
SCHEMBL19689580 0.83 MET (0.55) METKDR
SCHEMBL407662 0.83 MET (0.57) METAXL
SCHEMBL15519428 0.82 MET (0.53) METKDRAXL
SCHEMBL3830213 0.82 MET (0.47) METKDR
SCHEMBL3858219 0.81 MET (0.55) METKDR
SCHEMBL407663 0.81 MET (0.46) METKDR
SCHEMBL371857 0.80 MET (0.61) METKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2210607-B1 N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer EXELIXIS INC (US) 2011-08-17 — — EP disclosed
Send feedback